Skip to main content

Cannabis plants are seen during a tour of a Hexo Corp. production facility on Oct. 11, 2018 in Masson Angers, Que.

Adrian Wyld/The Canadian Press

Shares of Hexo Corp. slipped after the cannabis company posted a larger-than-expected fourth-quarter adjusted loss and an inventory writedown.

The Gatineau, Que.-based pot producer’s stock slipped as much as 10 per cent to $2.72 on the Toronto Stock Exchange, but regained some ground to close down roughly three per cent at $2.94.

“Our company’s still young, despite all that we’ve accomplished, we’ve had some shortfalls.... We hold ourselves accountable to that,” Hexo chief executive Sebastien St-Louis told a conference call with financial analysts Tuesday.

Story continues below advertisement

Hexo posted a net loss of $56.7-million in the quarter ended July 31, compared with a loss of $10.5-million in the same quarter a year ago. Net revenue totalled $15.4-million, up from $1.4-million in the same quarter last year before the legalization of recreational cannabis in Canada and $13.0-million in its third quarter.

It also took a $16.9-million inventory writedown and analysts said Hexo’s adjusted earnings before interest taxes, depreciation and amortization fell short of expectations.

Hexo did not provide an EBITDA figure in its quarterly release or financial statement, but Desjardins analyst John Chu estimated that it totalled a loss of $29.6-million, “well short” of the analyst’s forecast of a $11.8-million adjusted EBITDA loss.

BMO analyst Amy Chen said the writedown and Hexo citing “price compression” in the market “is an unsettling development considering the sizable amount of unfinished inventory held by LPs (339k kg as of August according to Health Canada),” she said in a note to clients.

The earnings came after Hexo announced it was reducing its work force by 200 jobs to adjust for expected future revenues and ensure the long-term viability of the firm. The cuts included the elimination of some executive positions and the departures of chief manufacturing officer Arno Groll and chief marketing officer Nick Davies.

Hexo also said earlier this month that its net revenue for the quarter ended July 31 would be in the range of between $14.5-million to $16.5-million, down from roughly $26-million it had forecast before, due to factors including a slow retail rollout and early pricing pressure.

The cannabis company also said it was withdrawing its previously issued outlook of up to $400-million in net revenue during its 2020 financial year.

Story continues below advertisement

In its latest outlook, Hexo said expects its first-quarter net revenue to be in a range from $14-million to $18-million.

The company provided cautious guidance for positive adjusted EBITDA in calendar 2020, “based on certain assumptions made by management regarding store counts in the various provinces as well as operational improvements and cost saving initiatives the company is seeking to implement.”

St-Louis also pulled back its previous forecast of eight U.S. states with products containing CBD, the non-intoxicating compound found in cannabis in hemp, saying it would be a more concentrated effort.

Hexo’s fourth-quarter results “continued a streak of disappointing updates,” said Owen Bennett, an analyst with Jefferies.

“EBITDA positive timing was pushed out, and with the magnitude of a U.S. launch downplayed and a derivatives roll out to be delayed, while at the same time urging caution around Q1 sales... Upside to be had if they can execute on plans but no one will give them credit for this until they actually deliver,” he said in a note to clients

St-Louis told analysts the future of the cannabis industry remains bright, but it may be slower to ramp up and it is unclear which players “will be Amazon and which will be the Pets.com and forgotten.”

Story continues below advertisement

“And I think if you look to the metrics and the way Hexo is managing its business, the way we are making hard decisions on operations, and the market share we’ve managed to keep, that tells a much stronger story than the quarterly revenue numbers,” he said.

Report an error
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies